fda warning semaglutide The has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and FDA Clears Semaglutide For Cardiac

The South Florida market for peptide therapy is large and largely unsupervised

Phase 3 data for Retatrutide is expected to clarify whether the 24.2% Phase 2 result is reproducible at scale, potentially making it the most effective single compound in this class

Shipping was fast and tracking was easy to follow

Akkermansia muciniphila treatment improves host metabolism Insulin resistance and metabolic syndrome are the most prominent characteristics of T2D, and A

What Pharma Should Actually Do The pharmaceutical industrys strategic response to the PBM reform moment needs to go beyond lobbying for balanced regulation and defending the current pricing architecture

, Shen, Q